Deadline is approaching! Are you doing research in #EGFR+ #lungcancer — OR mentoring someone who is — submit an abstract to the EGFR Resisters Research Summit Concepts welcome Deadline-August 8. Submit Abstract - ceconcepts.com/egfr-summit #NSCLC #ThoracicOnc #HOFellows #EGFRResisters #OncoAlert

OncoDaily@oncodaily.bsky.social · last yr.

Calling All Thoracic Oncology Leaders to Join Us at the 7th Annual EGFR Resisters Research Summit - Jill Feldman @jillfeldman4.bsky.social oncodaily.com/blog/jill-fe... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #EGFR #EGFRResisters #NSCLC

Welcome #pallonc #supponc folks to the official Blue Sky account for ASCO supported #PallOncCoP. Please follow for official Zoom meeting events, in-person conference meet ups like pic #ASCO24 and sharing the latest science in comfort and cure.

I will co-chair with Prof Maryam Lustberg on June 26th AM "Workshop 1: Partnering with patients in managing chronic toxicities of cancer and its treatment." bringing together multidisciplinary professionals, cancer patients, survivors and carers to compare best practices for management toxicities.

My Guiding Compass in Advocacy: Speak up, but do it with respect. Challenge, but do it with understanding. And always push forward with purpose — Real change happens through conversation, not confrontation. I was 28 when my mom died, but her profound wisdom always guides me 💙

Jill Feldman wrote a powerful article for @curetoday.bsky.social about the #LungCancerGeneticsStudy – a collaboration between nearly two dozen #LungCancer organizations and 23andme to uncover the genetic risks of lung cancer. Read it at: www.curetoday.com/view/the-pow... @jillfeldman4.bsky.social

The Power of Unity: Why the Lung Cancer Genetics Study Matters

The Lung Cancer Genetics Study, a collaboration between lung cancer advocacy organizations, aims to explore the genetics of lung cancer

curetoday.com

ASCO has a palliative care community of practice in which a patient advocate pillar was organized with @jillfeldman4.bsky.social, Ameish, and I as members. I have served since September 2023 as the lead and will hand over the role later this year.

Please email pallonccop@gmail.com to be added to the listserv.

Words Matter isn't just a catchphrase. It is a simple yet profound truth when talking about #lungcancer Thank you, Drs Jamie Ostroff & Smita Banerjee, for your efforts to develop a training that offers strategies for empathic communication to ⬇️ stigma bit.ly/4gWH1Si #LCSM #EndStigmaNow

Helping Health Professionals Reduce Lung Cancer Stigma

Researchers have developed a training program to help health providers reduce lung cancer stigma and have launched a clinical trial to test the training.

bit.ly

THIS! Easy-to-use, available regimen significantly ⬇️ frequency & severity of Grade 2+ AEs SOC for patients on first-line Ami/Lazer. Like “Stay ahead of the pain,” “Stay ahead of the side effects” boosts QOL & ⬇️ dose interrupt/discontine—a win for everyone. 👏 #LCSM #SuppOnc bit.ly/4jiKwUz

What a pleasure it was to meet Donghoon Shin! His passion and desire to learn from patient advocates was genuine and impressive. The future of #lungcancer research is bright😎 #LCSM #EGFR

Ivy Riano, MD@ivyrianomd.bsky.social · 2y ago

Congrats Donghoon Shin on receiving an honorable mention at the @EGFRSummit Your research and passion for the field are truly impressive #ProudMentor Huge shoutout to @EGFRResisters for giving trainees a platform to showcase their work! #LCSM 🙌🏼 @jillfeldman4.bsky.social

ICYMI "We must rethink how we define progress in oncology" #Oncosky #Cansky #Pallonc

Jill Feldman@jillfeldman4.bsky.social · 2y ago

Innovation shouldn't come at the expense of patient-centered care! Great article about prioritizing what matters to patients (QOL/OS/⬇️ burdens). It underscores palliative care being viewed as essential, not ancillary. We must rethink how we define progress in #oncology #pallonc #LCSM bit.ly/3OJQuQB

“The most common cause of death from cancer is from lung cancer…yet just 16% of eligible people get screened for lung cancer, far lower than screening rates for colorectal or breast cancer. “ #medsky ktul.com/news/nation-...

More people surviving lung cancer, but work remains in screening and biomarker testing

The American Lung Association has released its annual "State of Lung Cancer" report.

ktul.com

Innovation shouldn't come at the expense of patient-centered care! Great article about prioritizing what matters to patients (QOL/OS/⬇️ burdens). It underscores palliative care being viewed as essential, not ancillary. We must rethink how we define progress in #oncology #pallonc #LCSM bit.ly/3OJQuQB

The trade-off between accelerated cancer drug approvals and patient preferences

Cancer care stands at a critical juncture where the urgency of rapid drug approvals must be balanced against the need for enduring patient-centric benefits. Robin Forrest and colleagues1 conducted a d...

bit.ly

It was an honor to co-author this article bit.ly/40WN9Vr It emphasizes the profound impact of a #lungcancer dx, highlighting the multifaceted challenges patients/families face. It's time to transform the “one-way ticket” into an experience of hope, support & compassionate care. #LCAM #LCSM

Lung cancer—a one-way ticket

The physician’s duty is not to stave off death or return patients to their old lives, but to take into our arms a patient and family whose lives have disin

bit.ly

Working on the #ASCO #SCLC guidelines, published in 2023, was disheartening, but working on the rapid update (based on #ASCO24 data) left me emotional. This update represents hope & progress for patients who have waited far too long. ascopubs.org/doi/10.1200/... #LCSM

Systemic Therapy for Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update | Journal of Clinical Oncology

ASCO Rapid Recommendation Updates highlight revisions to select ASCO guideline recommendations as a response to the emergence of new and practice-changing data. The rapid updates are supported by an e...

ascopubs.org

Today's the day! Our last PallOncCoP meeting of 2024! Don't miss it. Not too late to DM📨 for Zoom 🔗. Always stay in the know by sending your prof email to pallonccop@gmail.com to be added to our listserv. @darcyburbage.bsky.social @tingtingzhang.bsky.social @jillfeldman4.bsky.social

@sarahlowry.bsky.social · 2y ago

Looking forward to sharing our experience next week!

The #lungcancer screening team at RushCancer Center has had a 50% uptake in screening for the 3rd year! Congratulations to Annie and the team, and thank you for your tireless efforts to raise awareness about lung cancer screening! #LCSM #LCAM #EarlyDetectionSavesLives

Great episode Dr Ross Camidge's podcast #HowThisIsBuildingMe with pharmacologist Dr. Zirkelbach (FDA Onc) on drug dev & her focus on #PROs for best outcomes w/fewest AEs I always learn, but still have questions about #ProjectOptimus bit.ly/48RlOpz #LCAM #LCSM #TheRightDose @itsnotpink.bsky.social

FDA Involvement in Dose Optimization Through Project Optimus Drives a Patient-Focused Oncology Pharmacology Career: With D. Ross Camidge, MD, PhD; and Jeanne Fourie Zirkelbach, PhD

Drs Camidge and Zirkelbach discuss Zirkelbach's first pharmacokinetics forays and her involvement with reforming dose optimization in drug development.

bit.ly

📢 The @ASCO released updated living guidelines for treating stage IV #NSCLC with driver alterations! ascopubs.org/doi/10.1200/.... This is no easy feat, but it was an honor to work alongside exceptional experts dedicated to providing the most up-to-date, evidence-based guidance. #LCSM #LCAM

Voting in the ASCO Election is open now until December 3! Meet the candidates for the Board of Directors – Undesignated Member seat. Learn more about each candidate, determine your voting eligibility, and make your voice heard at brnw.ch/21wOzu3

"the new generation of cancer survivor [is] younger, less financially secure, and still having to navigate life after treatment, from dating to career, sex and child rearing" So glad that #AYAcsm #survonc #financialToxicity & #MBC issues are getting time on NPR www.npr.org/2024/11/11/n...

I made a #LCSM list, small but growing! Not sure how to make it public? bsky.app/profile/did:... @jackwestmd.bsky.social @stephenvliu.bsky.social @pateloncology.bsky.social @tlblase.bsky.social @devikadasmd.bsky.social @jia-luo.bsky.social @garthnicholas.bsky.social